Looking ahead, future mechanistic in vitro studies hold the potential to unveil the functions of RASGEF1A and the 374459 isoform in immune blood cells, which could provide insights into the differential expression in PBMCs of BC patients. The gene discussed is RASGEF1A; the disease is breast cancer.